Muaiad Kittaneh, Senior Director at ICON, shared a post on LinkedIn by Syneos Health, adding:
“Proud to represent Syneos Health in this important oncology clinical trials conversation.
As oncology drug development continues to evolve, the opportunity is to design trials that are scientifically rigorous, operationally realistic, data-informed, and centered on the patients we serve.
I look forward to joining colleagues at the 15th Annual Clinical Trials in Oncology East Coast conference to discuss how innovation in trial design and execution can help accelerate the oncology patient journey.”
Quoting Syneos Health’s post:
“The future of oncology isn’t just about discovering new therapies. It’s about designing smarter, faster and more patient-centered clinical trials that help bring them to the people who need them.
Tomorrow, Muaiad Kittaneh, Global Head of R and D and Scientific Strategy at Syneos Health, will join industry leaders at the 15th Annual Clinical Trials in Oncology East Coast conference to discuss how innovation in trial design and data-driven decision-making can help transform the oncology patient journey.
If you’re attending, connect with Dr. Kittaneh to continue the conversation. And wherever you’re following from, stay connected with Syneos Health on LinkedIn as we share insights and perspectives from across the oncology landscape.”
Proceed to the video attached to the post.
Other articles featuring Muaiad Kittaneh on OncoDaily.